The global Gastrointestinal Therapeutics market is expected to reach a value of US$ 74.42 billion by 2029, growing at a CAGR of 5.59% during the forecast period.
Market Overview
As of the most recent Gastrointestinal Therapeutics Market update, the global economic landscape reflects a dynamic interplay of various factors. Major financial markets continue to navigate the aftermath of the unprecedented events that unfolded in recent years, such as the global pandemic and geopolitical shifts. Equities have demonstrated resilience amid ongoing uncertainties, propelled by technological advancements, innovation, and accommodative monetary policies. However, challenges persist, including inflationary pressures, supply chain disruptions, and regulatory changes in various sectors. Investors are closely monitoring central bank decisions, fiscal policies, and emerging trends to assess potential opportunities and risks. The market’s response to evolving conditions underscores the importance of adaptability and strategic planning for both businesses and investors in this complex and ever-changing environment.
Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/38877
Report Scope:
This report provides insights into the global gastrointestinal therapeutics market, covering market trends in various countries and competitive landscapes.
Research Methodology:
The research methodology employed for this report includes extensive data collection and analysis, focusing on market trends, drivers, restraints, segmentation, and regional insights.
Drivers:
The main driver of the gastrointestinal therapeutics market is the increasing acceptance of biologics for treating gastrointestinal diseases. The emergence of novel small molecules and cellular therapies such as tofacitinib and vedolizumab is significantly contributing to market growth.
Restraints:
While the market is poised for growth, factors such as promotion exclusivity granted by regulatory authorities to patent holders for different indications may hinder market development to some extent.
Segmentation:
The market analysis indicates that the generic segment is expected to grow exponentially during the forecast period, driven by patent expirations, cost-effectiveness of generics, and government initiatives to promote their usage.
by Type
Branded
Generics
by Route of Administration
Oral
Intravenous
Others
by Application
Ulcerative Colitis
Crohn’s Disease
GERD
Others
by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights:
North America dominated the market in 2022 and is expected to maintain its position throughout the forecast period. This can be attributed to lifestyle changes leading to a higher incidence of gastrointestinal diseases and government initiatives aimed at prevention and treatment.
Market Key Players
1. Abbott Laboratories
2. Allergan plc
3. AstraZeneca
4. Bayer AG
5. GlaxoSmithKline plc
6. Janssen Pharmaceuticals
7. Takeda Pharmaceuticals
8. Valeant Pharmaceuticals
9. Pfizer
10. AbbVie, Inc.
11. AstraZeneca
12. Shire
13. Valeant (Salix Pharmaceuticals)
14. Takeda Pharmaceutical Company Limited
15. Eisai Co. Ltd.
16. Johnson & Johnson Private Limited
17. Astellas Pharma Inc.
18. Novo Nordisk A/S
19. Sanofi S.A.
Get to Know More About This Market Study:https://www.maximizemarketresearch.com/market-report/global-gastrointestinal-therapeutics-market/38877/
Key questions answered in the Gastrointestinal Therapeutics Market report include:
What is Gastrointestinal Therapeutics?
What factors drive Gastrointestinal Therapeutics Market growth?
What are the main challenges for Gastrointestinal Therapeutics Market growth?
What was the Gastrointestinal Therapeutics market size in 2023?
Which trends are expected to contribute to Gastrointestinal Therapeutics market growth?
What recent industry trends can generate additional revenue streams for the Gastrointestinal Therapeutics Market?
What growth strategies are players considering to increase their foothold in the Gastrointestinal Therapeutics Market?
Who held the largest market share in the Gastrointestinal Therapeutics Market?
Key Offerings:
Past Market Size and Competitive Landscape (2021 to 2023)
Past Pricing and price curve by region (2021 to 2023)
Market Size, Share, Size & Forecast by different segment | 2023−2029
Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by region
Market Segmentation – A detailed analysis by segment with their sub-segments and Region
Competitive Landscape – Profiles of selected key players by region from a strategic perspective
Competitive landscape – Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER’s analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, IndiaC
+91 96071 95908, +91 9607365656
